BioAtla Inc. (BCAB) PT Raised to $8 at Credit Suisse
Tweet
Share
E-mailGet Alerts BCAB Hot Sheet
Price: $3.27 +2.83%
Rating Summary:
5 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Rating Summary:
5 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Join SI Premium – FREE
Credit Suisse analyst Tiago Fauth raised the price target on BioAtla Inc. (NASDAQ: BCAB) to $8.00 (from $4.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Bernstein SocGen Group Upgrades Analog Devices (ADI) to Outperform
- Centrus Energy Corp. (LEU) PT Raised to $185 at UBS
- Viking Holdings (VIK) PT Raised to $121 at UBS Ahead of Q2 Earnings
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
